Refractory Pain
11
3
4
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
18.2%
2 terminated out of 11 trials
50.0%
-36.6% vs benchmark
9%
1 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Single Arm, Monocentric, Pilot Feasibility Study on an Interactive Virtual Reality Program in 20 Complex In-clinic Palliative Care Patients
OP2C : Prialt® Observatory in Clinical Practice
Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)
Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia
Sham-Controlled RCT on 10kHz High-Frequency Spinal Cord Stimulation for Chronic Neuropathic Low Back Pain (Modulate-LBP)
Clinical Effect of LG Medipain for Managing Chronic Pain Disorders
Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)
Transcranial Direct-current Stimulation (tDCS) Efficacy in Refractory Cancer Pain.
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
Buprenorphine as a Treatment in Opiate Dependent Pain Patients